JASPER THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHWed, 15 Apr 2026 12:18:59 +0200https://images.finanzen.net/images/finanzen_net_neu.gifJASPER THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netJasper Therapeutics: Was beim Unternehmen in den jüngsten Büchern stehtWed, 01 Apr 2026 06:35:06 +0200https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-was-beim-unternehmen-in-den-juengsten-buechern-steht-15588286Jasper Therapeutics äußerte sich am 30.03.2026 zu den Geschäftsergebnissen des am 31.12.2025 abgelaufenen Quartals.Jasper Therapeutics hat im jüngsten Jahresviertel einen Verlust von 0,32 USD je Aktie erwirtschaftet. ...

]]>https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-was-beim-unternehmen-in-den-juengsten-buechern-steht-15588286Jasper Therapeutics legte Quartalsergebnis vorWed, 12 Nov 2025 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-legte-quartalsergebnis-vor-15264824Jasper Therapeutics hat in der Finanzkonferenz zum Quartalsende am 10.11.2025 die Bücher zum vergangenen Jahresviertel geöffnet, das am 30.09.2025 abgelaufen war.Es wurde ein Verlust je Aktie von 1,13 USD ...

]]>https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-legte-quartalsergebnis-vor-15264824Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPRTue, 28 Oct 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15132634

NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed ...

]]>https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15132634JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmMon, 27 Oct 2025 09:01:00 +0100https://www.finanzen.net/nachricht/aktien/jspr-investors-have-opportunity-to-lead-jasper-therapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15124336

LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/jspr-investors-have-opportunity-to-lead-jasper-therapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15124336Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPRMon, 27 Oct 2025 08:59:00 +0100https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-jspr-15124324

LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/jasper-therapeutics-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-jspr-15124324Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPRThu, 23 Oct 2025 16:00:00 +0200https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15111616

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed ...

]]>https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15111616JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmMon, 20 Oct 2025 09:30:00 +0200https://www.finanzen.net/nachricht/aktien/jspr-investors-have-opportunity-to-lead-jasper-therapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15095962

LOS ANGELES, Oct. 20, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/jspr-investors-have-opportunity-to-lead-jasper-therapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15095962Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPRSat, 18 Oct 2025 16:00:00 +0200https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15092634

NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed ...

]]>https://www.finanzen.net/nachricht/aktien/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-jasper-therapeutics-inc-and-certain-officers-jspr-15092634